This corroborates our previous study, which showed that bladder tumour cell lines containing mutant RAS were intrinsically resistant to FGFR inhibition [17] and a recent finding of resistance due to overexpressed wild type HRAS in FGFR‐dependent cell lines, including RT112 [28]. Here, HRAS is linked to urinary bladder neoplasm.